Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
Top Cited Papers
- 1 February 2005
- journal article
- genitourinary cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (4) , 832-841
- https://doi.org/10.1200/jco.2005.05.179
Abstract
Purpose To validate the Motzer et al prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma (RCC) and to identify additional independent prognos...Keywords
This publication has 27 references indexed in Scilit:
- When Will Melanoma Vaccines Be Proven Effective?Journal of Clinical Oncology, 2004
- Phase I's, Photons, and Philosophies: New Tactics for Exploratory Clinical Trials of Concurrent ChemoradiationJournal of Clinical Oncology, 2004
- Randomized Multicenter Phase II Trial of Subcutaneous Recombinant Human Interleukin-12 Versus Interferon-α2a for Patients with Advanced Renal Cell CarcinomaJournal of Interferon & Cytokine Research, 2001
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Phase II Trial of Interleukin-2 and Interferon-ce in Patients with Renal Cell Carcinoma: Clinical Results and Immunologic Correlates of ResponseJournal of Immunotherapy, 1997
- Prognostic factors in renal cell carcinomaBritish Journal of Urology, 1995
- Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-αEuropean Journal Of Cancer, 1994
- Prognostic factors of adult metastatic renal carcinoma: A multivariate analysisSeminars in Surgical Oncology, 1988
- Albumin as an aid to the interpretation of serum calciumClinica Chimica Acta; International Journal of Clinical Chemistry, 1971
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958